Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Aug 8:78:100264.
doi: 10.1016/j.clinsp.2023.100264. eCollection 2023.

CT radiomics for prediction of microvascular invasion in hepatocellular carcinoma: A systematic review and meta-analysis

Affiliations
Meta-Analysis

CT radiomics for prediction of microvascular invasion in hepatocellular carcinoma: A systematic review and meta-analysis

Hai-Ying Zhou et al. Clinics (Sao Paulo). .

Abstract

The power of computed tomography (CT) radiomics for preoperative prediction of microvascular invasion (MVI) in hepatocellular carcinoma (HCC) demonstrated in current research is variable. This systematic review and meta-analysis aim to evaluate the value of CT radiomics for MVI prediction in HCC, and to investigate the methodologic quality in the workflow of radiomics research. Databases of PubMed, Embase, Web of Science, and Cochrane Library were systematically searched. The methodologic quality of included studies was assessed. Validation data from studies with Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) statement type 2a or above were extracted for meta-analysis. Eleven studies were included, among which nine were eligible for meta-analysis. Radiomics quality scores of the enrolled eleven studies varied from 6 to 17, accounting for 16.7%-47.2% of the total points, with an average score of 14. Pooled sensitivity, specificity, and Area Under the summary receiver operator Characteristic Curve (AUC) were 0.82 (95% CI 0.77-0.86), 0.79 (95% CI 0.75-0.83), and 0.87 (95% CI 0.84-0.91) for the predictive performance of CT radiomics, respectively. Meta-regression and subgroup analyses showed radiomics model based on 3D tumor segmentation, and deep learning model achieved superior performances compared to 2D segmentation and non-deep learning model, respectively (AUC: 0.93 vs. 0.83, and 0.97 vs. 0.83, respectively). This study proves that CT radiomics could predict MVI in HCC. The heterogeneity of the included studies precludes a definition of the role of CT radiomics in predicting MVI, but methodology warrants uniformization in the radiology community regarding radiomics in HCC.

Keywords: Computed tomography; Hepatocellular carcinoma; Meta-analysis; Microvascular invasion; Radiomics; Systematic review.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Flowchart of study selection.
Fig. 2
Fig. 2
Methodologic quality assessment of the included studies based on the QUADAS-2 scale. (a) Individual studies, and (b) summary.
Fig. 3
Fig. 3
Deeks’ funnel plot. The plot shows no asymmetry and presence of publication bias.
Fig. 4
Fig. 4
Forest plots show the performance estimates of each study with computed tomography radiomics for preoperative microvascular invasion evaluation in hepatocellular carcinoma. (a) Sensitivity, (b) Specificity, (c) Positive Likely Ratio (LR), and (d) Negative LR.
Fig. 5
Fig. 5
Summary Receiver Operating Characteristic (SROC) curve of computed tomography radiomics for preoperative microvascular invasion evaluation in hepatocellular carcinoma.

Similar articles

Cited by

References

    1. Forner A., Reig M., Bruix J. Hepatocellular carcinoma. Lancet. 2019;391(10127):1301–1314. - PubMed
    1. Marrero J.A., Kulik L.M., Sirlin C.B., Zhu A.X., Finn R.S., Abecassis M.M., et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the. Hepatology. 2018;68(2):723–750. - PubMed
    1. Erstad D.J., Tanabe K.K. Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma. Ann Surg Oncol. 2019;26(5):1474–1493. - PubMed
    1. Rastogi A. Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma. World J Gastroenterol. 2018;24(35):4000–4013. - PMC - PubMed
    1. Reginelli A., Vacca G., Segreto T., Picascia R., Clemente A., Urraro1 F., et al. Can microvascular invasion in hepatocellular carcinoma be predicted by diagnostic imaging? A critical review. Future Oncol. 2018;14(28):2985–2994. - PubMed

MeSH terms